Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)

NCT00411281 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00411281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00411281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Withdrawn
Start date
March 31, 2006
Completion date
November 30, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia